nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP2B6—Ifosfamide—testicular cancer	0.0915	0.124	CbGbCtD
Clopidogrel—CYP3A5—Ifosfamide—testicular cancer	0.072	0.0979	CbGbCtD
Clopidogrel—CYP2C8—Ifosfamide—testicular cancer	0.0693	0.0942	CbGbCtD
Clopidogrel—CYP2C19—Ifosfamide—testicular cancer	0.0581	0.079	CbGbCtD
Clopidogrel—CYP2C9—Ifosfamide—testicular cancer	0.0483	0.0657	CbGbCtD
Clopidogrel—CYP2B6—Cisplatin—testicular cancer	0.0445	0.0605	CbGbCtD
Clopidogrel—ABCB1—Dactinomycin—testicular cancer	0.0397	0.054	CbGbCtD
Clopidogrel—CYP3A5—Etoposide—testicular cancer	0.0344	0.0468	CbGbCtD
Clopidogrel—CYP2C8—Etoposide—testicular cancer	0.0331	0.045	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—testicular cancer	0.0298	0.0405	CbGbCtD
Clopidogrel—CYP3A4—Ifosfamide—testicular cancer	0.0281	0.0382	CbGbCtD
Clopidogrel—CYP1A2—Etoposide—testicular cancer	0.0256	0.0348	CbGbCtD
Clopidogrel—ABCB1—Vinblastine—testicular cancer	0.0249	0.0338	CbGbCtD
Clopidogrel—CYP2C9—Cisplatin—testicular cancer	0.0235	0.0319	CbGbCtD
Clopidogrel—ABCB1—Cisplatin—testicular cancer	0.0228	0.031	CbGbCtD
Clopidogrel—ABCB1—Etoposide—testicular cancer	0.0224	0.0305	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—testicular cancer	0.0153	0.0208	CbGbCtD
Clopidogrel—CYP3A4—Vinblastine—testicular cancer	0.0149	0.0203	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—testicular cancer	0.0148	0.0201	CbGbCtD
Clopidogrel—CYP3A4—Etoposide—testicular cancer	0.0134	0.0183	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—testicular cancer	0.00916	0.0124	CbGbCtD
Clopidogrel—Hepatobiliary disease—Methotrexate—testicular cancer	0.000211	0.000798	CcSEcCtD
Clopidogrel—Epistaxis—Methotrexate—testicular cancer	0.00021	0.000796	CcSEcCtD
Clopidogrel—Pneumonia—Epirubicin—testicular cancer	0.00021	0.000794	CcSEcCtD
Clopidogrel—Nausea—Bleomycin—testicular cancer	0.000209	0.000791	CcSEcCtD
Clopidogrel—Vomiting—Dactinomycin—testicular cancer	0.000209	0.000789	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—testicular cancer	0.000208	0.000788	CcSEcCtD
Clopidogrel—Agranulocytosis—Methotrexate—testicular cancer	0.000208	0.000787	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000207	0.000783	CcSEcCtD
Clopidogrel—Rash—Dactinomycin—testicular cancer	0.000207	0.000783	CcSEcCtD
Clopidogrel—Diarrhoea—Ifosfamide—testicular cancer	0.000206	0.000778	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—testicular cancer	0.000206	0.000778	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—testicular cancer	0.000205	0.000776	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Etoposide—testicular cancer	0.000205	0.000776	CcSEcCtD
Clopidogrel—Body temperature increased—Cisplatin—testicular cancer	0.000205	0.000775	CcSEcCtD
Clopidogrel—Fatigue—Etoposide—testicular cancer	0.000205	0.000775	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—testicular cancer	0.000205	0.000774	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—testicular cancer	0.000203	0.00077	CcSEcCtD
Clopidogrel—Pain—Etoposide—testicular cancer	0.000203	0.000768	CcSEcCtD
Clopidogrel—Constipation—Etoposide—testicular cancer	0.000203	0.000768	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—testicular cancer	0.000203	0.000768	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—testicular cancer	0.000203	0.000768	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—testicular cancer	0.000203	0.000766	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000201	0.000762	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—testicular cancer	0.000201	0.000761	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—testicular cancer	0.0002	0.000758	CcSEcCtD
Clopidogrel—Hepatitis—Methotrexate—testicular cancer	0.0002	0.000758	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—testicular cancer	0.000199	0.000753	CcSEcCtD
Clopidogrel—Dizziness—Ifosfamide—testicular cancer	0.000199	0.000752	CcSEcCtD
Clopidogrel—Urinary tract disorder—Methotrexate—testicular cancer	0.000198	0.000748	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—testicular cancer	0.000197	0.000747	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—testicular cancer	0.000197	0.000745	CcSEcCtD
Clopidogrel—Urethral disorder—Methotrexate—testicular cancer	0.000196	0.000743	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—testicular cancer	0.000196	0.000741	CcSEcCtD
Clopidogrel—Feeling abnormal—Etoposide—testicular cancer	0.000196	0.00074	CcSEcCtD
Clopidogrel—Nausea—Dactinomycin—testicular cancer	0.000195	0.000737	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—testicular cancer	0.000195	0.000737	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—testicular cancer	0.000194	0.000735	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Etoposide—testicular cancer	0.000194	0.000735	CcSEcCtD
Clopidogrel—Visual impairment—Methotrexate—testicular cancer	0.000193	0.00073	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000192	0.000724	CcSEcCtD
Clopidogrel—Vomiting—Ifosfamide—testicular cancer	0.000191	0.000723	CcSEcCtD
Clopidogrel—Hypersensitivity—Cisplatin—testicular cancer	0.000191	0.000723	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—testicular cancer	0.00019	0.000718	CcSEcCtD
Clopidogrel—Rash—Ifosfamide—testicular cancer	0.00019	0.000717	CcSEcCtD
Clopidogrel—Dermatitis—Ifosfamide—testicular cancer	0.000189	0.000717	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—testicular cancer	0.000189	0.000716	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000189	0.000716	CcSEcCtD
Clopidogrel—Urticaria—Etoposide—testicular cancer	0.000189	0.000714	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—testicular cancer	0.000188	0.000713	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—testicular cancer	0.000188	0.000712	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—testicular cancer	0.000188	0.000711	CcSEcCtD
Clopidogrel—Body temperature increased—Etoposide—testicular cancer	0.000188	0.00071	CcSEcCtD
Clopidogrel—Abdominal pain—Etoposide—testicular cancer	0.000188	0.00071	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—testicular cancer	0.000188	0.00071	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—testicular cancer	0.000188	0.00071	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—testicular cancer	0.000187	0.000709	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—testicular cancer	0.000187	0.000709	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—testicular cancer	0.000187	0.000708	CcSEcCtD
Clopidogrel—Tinnitus—Methotrexate—testicular cancer	0.000187	0.000706	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—testicular cancer	0.000186	0.000705	CcSEcCtD
Clopidogrel—Asthenia—Cisplatin—testicular cancer	0.000186	0.000704	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—testicular cancer	0.000185	0.0007	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—testicular cancer	0.000185	0.000698	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—testicular cancer	0.000184	0.000697	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—testicular cancer	0.000184	0.000695	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000183	0.000691	CcSEcCtD
Clopidogrel—Epistaxis—Doxorubicin—testicular cancer	0.000182	0.000689	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—testicular cancer	0.000182	0.000687	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—testicular cancer	0.000181	0.000686	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—testicular cancer	0.000181	0.000684	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—testicular cancer	0.000181	0.000683	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—testicular cancer	0.00018	0.000683	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—testicular cancer	0.00018	0.000682	CcSEcCtD
Clopidogrel—Nausea—Ifosfamide—testicular cancer	0.000179	0.000676	CcSEcCtD
Clopidogrel—Diarrhoea—Cisplatin—testicular cancer	0.000177	0.000671	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—testicular cancer	0.000177	0.00067	CcSEcCtD
Clopidogrel—Mental disorder—Methotrexate—testicular cancer	0.000175	0.000664	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—testicular cancer	0.000175	0.000663	CcSEcCtD
Clopidogrel—Hypersensitivity—Etoposide—testicular cancer	0.000175	0.000662	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—testicular cancer	0.000175	0.000661	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—testicular cancer	0.000174	0.000659	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—testicular cancer	0.000174	0.000659	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—testicular cancer	0.000174	0.000658	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—testicular cancer	0.000173	0.000656	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—testicular cancer	0.000173	0.000656	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—testicular cancer	0.000173	0.000653	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—testicular cancer	0.000171	0.000648	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—testicular cancer	0.000171	0.000646	CcSEcCtD
Clopidogrel—Asthenia—Etoposide—testicular cancer	0.00017	0.000645	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—testicular cancer	0.00017	0.000643	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—testicular cancer	0.00017	0.000643	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—testicular cancer	0.000169	0.00064	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—testicular cancer	0.000169	0.000639	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—testicular cancer	0.000169	0.000638	CcSEcCtD
Clopidogrel—Pruritus—Etoposide—testicular cancer	0.000168	0.000636	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—testicular cancer	0.000167	0.000632	CcSEcCtD
Clopidogrel—Vomiting—Cisplatin—testicular cancer	0.000165	0.000624	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—testicular cancer	0.000164	0.000621	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—testicular cancer	0.000164	0.00062	CcSEcCtD
Clopidogrel—Rash—Cisplatin—testicular cancer	0.000163	0.000618	CcSEcCtD
Clopidogrel—Dermatitis—Cisplatin—testicular cancer	0.000163	0.000618	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—testicular cancer	0.000163	0.000617	CcSEcCtD
Clopidogrel—Diarrhoea—Etoposide—testicular cancer	0.000163	0.000615	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—testicular cancer	0.000162	0.000613	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—testicular cancer	0.000162	0.000612	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—testicular cancer	0.000161	0.000609	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—testicular cancer	0.000161	0.000608	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—testicular cancer	0.000158	0.000597	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—testicular cancer	0.000157	0.000595	CcSEcCtD
Clopidogrel—Dizziness—Etoposide—testicular cancer	0.000157	0.000594	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—testicular cancer	0.000157	0.000593	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—testicular cancer	0.000157	0.000592	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—testicular cancer	0.000157	0.000592	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—testicular cancer	0.000156	0.000591	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—testicular cancer	0.000156	0.00059	CcSEcCtD
Clopidogrel—Nausea—Cisplatin—testicular cancer	0.000154	0.000583	CcSEcCtD
Clopidogrel—Cough—Methotrexate—testicular cancer	0.000152	0.000575	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—testicular cancer	0.000152	0.000575	CcSEcCtD
Clopidogrel—Vomiting—Etoposide—testicular cancer	0.000151	0.000571	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—testicular cancer	0.000151	0.000571	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—testicular cancer	0.000151	0.00057	CcSEcCtD
Clopidogrel—Rash—Etoposide—testicular cancer	0.00015	0.000567	CcSEcCtD
Clopidogrel—Dermatitis—Etoposide—testicular cancer	0.00015	0.000566	CcSEcCtD
Clopidogrel—Headache—Etoposide—testicular cancer	0.000149	0.000563	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—testicular cancer	0.000149	0.000563	CcSEcCtD
Clopidogrel—Arthralgia—Methotrexate—testicular cancer	0.000148	0.000561	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—testicular cancer	0.000148	0.000561	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—testicular cancer	0.000148	0.000561	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000147	0.000558	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—testicular cancer	0.000147	0.000554	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—testicular cancer	0.000146	0.000553	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—testicular cancer	0.000146	0.000552	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—testicular cancer	0.000146	0.000552	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—testicular cancer	0.000145	0.000549	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—testicular cancer	0.000144	0.000545	CcSEcCtD
Clopidogrel—Confusional state—Methotrexate—testicular cancer	0.000143	0.000543	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—testicular cancer	0.000143	0.000542	CcSEcCtD
Clopidogrel—Cough—Epirubicin—testicular cancer	0.000142	0.000539	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—testicular cancer	0.000142	0.000538	CcSEcCtD
Clopidogrel—Infection—Methotrexate—testicular cancer	0.000141	0.000535	CcSEcCtD
Clopidogrel—Nausea—Etoposide—testicular cancer	0.000141	0.000534	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—testicular cancer	0.000141	0.000533	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—testicular cancer	0.00014	0.000528	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—testicular cancer	0.00014	0.000528	CcSEcCtD
Clopidogrel—Arthralgia—Epirubicin—testicular cancer	0.000139	0.000525	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—testicular cancer	0.000139	0.000525	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—testicular cancer	0.000139	0.000525	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—testicular cancer	0.000138	0.000524	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—testicular cancer	0.000138	0.000523	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000138	0.000522	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—testicular cancer	0.000136	0.000513	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—testicular cancer	0.000135	0.000512	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—testicular cancer	0.000135	0.000511	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—testicular cancer	0.000134	0.000508	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—testicular cancer	0.000133	0.000505	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—testicular cancer	0.000133	0.000504	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—testicular cancer	0.000133	0.000504	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—testicular cancer	0.000133	0.000503	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—testicular cancer	0.000133	0.000502	CcSEcCtD
Clopidogrel—Infection—Epirubicin—testicular cancer	0.000132	0.0005	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—testicular cancer	0.000132	0.000498	CcSEcCtD
Clopidogrel—Shock—Epirubicin—testicular cancer	0.000131	0.000496	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—testicular cancer	0.000131	0.000494	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—testicular cancer	0.00013	0.000493	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00013	0.00049	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—testicular cancer	0.000129	0.000489	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—testicular cancer	0.000129	0.000487	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—testicular cancer	0.000129	0.000486	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—testicular cancer	0.000129	0.000486	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—testicular cancer	0.000129	0.000486	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—testicular cancer	0.000128	0.000484	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—testicular cancer	0.000128	0.000483	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000128	0.000483	CcSEcCtD
Clopidogrel—Dyspnoea—Methotrexate—testicular cancer	0.000127	0.00048	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—testicular cancer	0.000125	0.000474	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—testicular cancer	0.000124	0.000471	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—testicular cancer	0.000124	0.00047	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—testicular cancer	0.000123	0.000466	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—testicular cancer	0.000123	0.000466	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000123	0.000465	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—testicular cancer	0.000123	0.000464	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—testicular cancer	0.000122	0.000463	CcSEcCtD
Clopidogrel—Pain—Methotrexate—testicular cancer	0.000122	0.00046	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000121	0.000459	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—testicular cancer	0.000121	0.000458	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—testicular cancer	0.000121	0.000457	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—testicular cancer	0.00012	0.000456	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—testicular cancer	0.00012	0.000453	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—testicular cancer	0.00012	0.000452	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—testicular cancer	0.000119	0.000449	CcSEcCtD
Clopidogrel—Feeling abnormal—Methotrexate—testicular cancer	0.000117	0.000443	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—testicular cancer	0.000117	0.000443	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—testicular cancer	0.000116	0.00044	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—testicular cancer	0.000115	0.000435	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000115	0.000435	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—testicular cancer	0.000115	0.000434	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—testicular cancer	0.000114	0.000431	CcSEcCtD
Clopidogrel—Pain—Epirubicin—testicular cancer	0.000114	0.000431	CcSEcCtD
Clopidogrel—Urticaria—Methotrexate—testicular cancer	0.000113	0.000428	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—testicular cancer	0.000112	0.000425	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—testicular cancer	0.000112	0.000425	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000112	0.000425	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—testicular cancer	0.000111	0.000421	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—testicular cancer	0.000111	0.000418	CcSEcCtD
Clopidogrel—Dyspnoea—Doxorubicin—testicular cancer	0.00011	0.000415	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—testicular cancer	0.00011	0.000415	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—testicular cancer	0.000109	0.000412	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—testicular cancer	0.000108	0.00041	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000106	0.000402	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—testicular cancer	0.000106	0.000402	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—testicular cancer	0.000106	0.0004	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—testicular cancer	0.000105	0.000399	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—testicular cancer	0.000105	0.000399	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—testicular cancer	0.000105	0.000398	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—testicular cancer	0.000105	0.000398	CcSEcCtD
Clopidogrel—Hypersensitivity—Methotrexate—testicular cancer	0.000105	0.000397	CcSEcCtD
Clopidogrel—Asthenia—Methotrexate—testicular cancer	0.000102	0.000386	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—testicular cancer	0.000102	0.000384	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000101	0.000381	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—testicular cancer	0.000101	0.000381	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—testicular cancer	9.81e-05	0.000371	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—testicular cancer	9.79e-05	0.00037	CcSEcCtD
Clopidogrel—Abdominal pain—Doxorubicin—testicular cancer	9.74e-05	0.000368	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—testicular cancer	9.74e-05	0.000368	CcSEcCtD
Clopidogrel—Diarrhoea—Methotrexate—testicular cancer	9.73e-05	0.000368	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—testicular cancer	9.55e-05	0.000361	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—testicular cancer	9.42e-05	0.000356	CcSEcCtD
Clopidogrel—Dizziness—Methotrexate—testicular cancer	9.41e-05	0.000356	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—testicular cancer	9.11e-05	0.000345	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—testicular cancer	9.08e-05	0.000343	CcSEcCtD
Clopidogrel—Vomiting—Methotrexate—testicular cancer	9.05e-05	0.000342	CcSEcCtD
Clopidogrel—Rash—Methotrexate—testicular cancer	8.97e-05	0.000339	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—testicular cancer	8.96e-05	0.000339	CcSEcCtD
Clopidogrel—Headache—Methotrexate—testicular cancer	8.91e-05	0.000337	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—testicular cancer	8.84e-05	0.000334	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—testicular cancer	8.8e-05	0.000333	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—testicular cancer	8.72e-05	0.00033	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—testicular cancer	8.47e-05	0.00032	CcSEcCtD
Clopidogrel—Nausea—Methotrexate—testicular cancer	8.45e-05	0.00032	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—testicular cancer	8.43e-05	0.000319	CcSEcCtD
Clopidogrel—Rash—Epirubicin—testicular cancer	8.39e-05	0.000318	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—testicular cancer	8.39e-05	0.000317	CcSEcCtD
Clopidogrel—Headache—Epirubicin—testicular cancer	8.34e-05	0.000316	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—testicular cancer	8.15e-05	0.000308	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—testicular cancer	7.91e-05	0.000299	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—testicular cancer	7.83e-05	0.000296	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—testicular cancer	7.77e-05	0.000294	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—testicular cancer	7.76e-05	0.000294	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—testicular cancer	7.72e-05	0.000292	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—testicular cancer	7.32e-05	0.000277	CcSEcCtD
